Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

3.04
Delayed Data
As of Mar 05
 +0.04 / +1.33%
Today’s Change
2.81
Today|||52-Week Range
15.00
-48.39%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close3.00
Today’s open3.00
Day’s range-- - --
Volume251,123
Average volume (3 months)207,945
Market cap$106.1M
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)+93.80%
Earnings growth (this year)-94.11%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GTXIGTX Inc+0.08+10.53%
CTRVContraVir Pharmaceut...+0.10+2.13%
AQXPAquinox Pharmaceutic...-0.14-1.37%
TNXPTonix Pharmaceutical...-0.08-1.25%
Data as of 03/05/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$0.00
Annual profit (last year)-$10.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Kaushik J. Dave
Chief Operating &
Medical Officer
Dragan Cicic
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account